ID
22685
Descripción
Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4168g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus
Palabras clave
Versiones (2)
- 7/6/17 7/6/17 -
- 9/6/17 9/6/17 -
Subido en
9 de junio de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
STUDY DRUG ADMINISTRATION DAY 0 CRFs Roche FVF4168G Macular Edema NCT00473330
STUDY DRUG ADMINISTRATION DAY 0 CRFs Roche FVF4168G Macular Edema NCT00473330
Similar models
STUDY DRUG ADMINISTRATION DAY 0 CRFs Roche FVF4168G Macular Edema NCT00473330
C0229089 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0229090 (UMLS CUI [2,2])
C0032042 (UMLS CUI [2])
C0011008 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])
C0042164 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,2])
C0234632 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,2])
C0578862 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,2])
C2880797 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,2])
C3714514 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,2])
C0038901 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])